On 25 April 2019, Aedifica launched a public capital increase in cash with irreducible priority allocation rights for its existing shareholders, in order to allow the company to 1) partly refinance the acquisition of a healthcare real estate portfolio in the United Kingdom, 2) finance its existing development pipeline and 3) increase its equity in order to continue its growth strategy in relation to its property portfolio, while maintaining an appropriate debt-to-assets ratio of approximately 50 to 55%.

Aedifica is a regulated real estate company under Belgian law (BE-REIT) specialising in healthcare real estate, particularly senior housing, with activities in Belgium, Germany, the Netherlands and the United Kingdom.

During the subscription period with irreducible priority allocation rights, which closed on 2 May 2019, 89.15% of the 6,147,142 offered new shares were subscribed. The remaining offered new shares were sold in the form of scrips through an exempt accelerated private placement on 3 May 2019. This transaction allowed Aedifica to raise approximately EUR 418 million, the envisaged maximum amount of the capital increase. Eubelius advised Aedifica on the realisation of this successful capital increase.